BE854416A - Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation - Google Patents

Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation

Info

Publication number
BE854416A
BE854416A BE177401A BE177401A BE854416A BE 854416 A BE854416 A BE 854416A BE 177401 A BE177401 A BE 177401A BE 177401 A BE177401 A BE 177401A BE 854416 A BE854416 A BE 854416A
Authority
BE
Belgium
Prior art keywords
menopause
symptoms
treatment
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
BE177401A
Other languages
English (en)
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of BE854416A publication Critical patent/BE854416A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE177401A 1976-05-10 1977-05-09 Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation BE854416A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68494976A 1976-05-10 1976-05-10

Publications (1)

Publication Number Publication Date
BE854416A true BE854416A (fr) 1977-09-01

Family

ID=24750187

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177401A BE854416A (fr) 1976-05-10 1977-05-09 Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation

Country Status (3)

Country Link
US (1) US4096254A (fr)
BE (1) BE854416A (fr)
ZA (1) ZA772086B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
FR2656309B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical ethyle substitue, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
SE9301171D0 (sv) * 1993-04-07 1993-04-07 Ab Astra Pharmaceutical composition containing lipophilic drugs
US5612317A (en) * 1994-08-04 1997-03-18 Holick; Michael F. Method for delivering estrogen
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5874084A (en) * 1996-07-19 1999-02-23 Yng-Wong; Quing Non Using complex herbal formulations to treat hot flashes
US6692763B1 (en) * 1998-11-19 2004-02-17 The Regents Of The University Of California Methods for treating postmenopausal women using ultra-low doses of estrogen
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US6395757B1 (en) * 1998-08-31 2002-05-28 Arthur M. Bobrove Method for treating hot flashes in humans
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
MXPA01008598A (es) * 1999-02-24 2003-06-24 Szabo Joseph Composiciones y metodos dieteticos.
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
GB2365769A (en) 2000-08-18 2002-02-27 Secr Defence Skin preparations containing silicon
US6881795B2 (en) * 2001-03-28 2005-04-19 Firestone Polymers, Llc CO2 terminated rubber for plastics
CA2778823A1 (fr) * 2006-04-04 2007-10-11 Nestec S.A. Traitements a la citrulline
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8716409B2 (en) * 2006-12-29 2014-05-06 Firestone Polymers, Llc Carboxylate terminated polymers and their use in impact-modified plastics
US8053004B2 (en) * 2007-10-08 2011-11-08 Starmaker Products, Llc Ointment for topical treatment of hot flashes and method of use
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022769A (en) * 1974-05-13 1977-05-10 Richardson-Merrell Inc. Androst-4-en-19-ones

Also Published As

Publication number Publication date
ZA772086B (en) 1978-06-28
US4096254A (en) 1978-06-20

Similar Documents

Publication Publication Date Title
BE854416A (fr) Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation
BE870055A (fr) Compositions et procede pour le traitement des calculs renaux
FR2503562B1 (fr) Conditionnement pharmaceutique pour le traitement des symptomes de menopause
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
BE855032A (fr) Compositions pharmaceutiques pour opacification barytee et leur procede de preparation
MA18939A1 (fr) Procede de preparation d'un agent pour le traitement de theilerioses
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
FR2333515A1 (fr) Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
BE885290A (fr) Compositions pharmaceutiques pour le traitement des hyperlipidemies et des hyperlipoproteinemies
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE856740A (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE871753A (fr) Nouvelle utilisation therapeutique de l'acetyl-1-carnitine pour le traitement des affections cardiaques
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
BE854412A (fr) Compositions pharmaceutiques pour un traitement gynecologique
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
FR2296415A1 (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
FR2341305A1 (fr) Nouveaux comprimes et nouvelle composition pour le traitement des troubles du systeme circulatoire cerebral, et leur preparation
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
FR2310768A1 (fr) Medicament pour le traitement de l'alopecia senilis
BE881763A (fr) Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension
BE865891A (fr) Nouvelles compositions pharmaceutiques destine notamment au traitement des troubles fonctionnels cerebraux

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: RICHARDSON-MERRELL INC.

Effective date: 19920531